Thus, to further clarify how MET is expressed in MM, we investigated the frequency of MET-GCNG/GA and expression by FISH and IHC in 155 consecutive MM cases, employing strictly defined criteria previously applied to a cancer type with significant heterogeneity of MET abnormalities, such as NSCLC [16,17]. The gene discussed is MET; the disease is cancer.